fluorodeoxyglucose f18 has been researched along with Cancer of Endocrine Gland in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofman, MS; Pattison, DA | 1 |
| Hicks, RJ; Pacak, K; Taïeb, D | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN | 1 |
| Boucher, E; Bouriel, C; Cuggia, M; de Lajarte-Thirouard, AS; Devillers, A; Garin, E; Le Jeune, F; Raoul, JL | 1 |
| Al-Nahhas, A; El-Refai, S; Hodolic, M; Khan, S; Marzola, MC; Naji, M; Rubello, D | 1 |
| Dudczak, R; Traub-Weidinger, T | 1 |
| Abgral, R; Aupérin, A; Baudin, E; de Baere, T; Déandreis, D; Dromain, C; Ducreux, M; Duvillard, P; Elias, D; Guigay, J; Leboulleux, S; Lumbroso, J; Schlumberger, M | 1 |
| Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
| Borson-Chazot, F; Chayvialle, JA; Janier, M; Kryza, D; Le Bars, D; Nejjari, M; Perek, N; Poncet, G; Roche, C; Scoazec, JY | 1 |
| Al-Nahhas, A; Khan, S; Lloyd, C; Rubello, D; Szyszko, T; Win, Z | 1 |
6 review(s) available for fluorodeoxyglucose f18 and Cancer of Endocrine Gland
| Article | Year |
|---|---|
Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies.
Topics: Endocrine Gland Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Carcinoma, Neuroendocrine; Catecholamines; Cushing Syndrome; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
PET and PET/CT in endocrine tumours.
Topics: Carbon Radioisotopes; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
PET imaging in endocrine tumours.
Topics: Adrenal Gland Neoplasms; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
5 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Endocrine Gland
| Article | Year |
|---|---|
PET Imaging for Endocrine Malignancies: From Woe to Go.
Topics: Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ileal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography | 2009 |
Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
Topics: Adult; Aged; Disease Progression; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin | 2009 |
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.
Topics: Aged; Cell Proliferation; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Survival Analysis; Tomography, X-Ray Computed | 2011 |
In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Choline; Digestive System Neoplasms; Endocrine Gland Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mice; Neoplasm Metastasis; Radionuclide Imaging | 2008 |